Cognition Therapeutics, Inc. (CGTX) Financials
CGTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 38.8 million | 9.8 million |
2023-06-30 | 44.0 million | 9.6 million |
2023-03-31 | 45.7 million | 9.9 million |
2022-12-31 | 50.4 million | 10.2 million |
CGTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.2 million | 1.1 million |
2023-06-30 | -3.7 million | 1.0 million |
2023-03-31 | -2.7 million | 1.2 million |
2022-12-31 | -10.2 million | 902000 |
CGTX Net Income
No data available :(
CGTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 33.0 million | - | 735000 |
2023-06-30 | 37.2 million | - | 774000 |
2023-03-31 | 38.8 million | - | 808000 |
2022-12-31 | 41.6 million | - | 844000 |
CGTX Shares Outstanding
CGTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 58000 | 11.7 million | 3.1 million | - |
2023-06-30 | 18000 | 8.5 million | 3.3 million | - |
2023-03-31 | 41000 | 5.4 million | 3.5 million | - |
2022-12-31 | 10000 | 6.4 million | 2.9 million | - |
CGTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 65000 |
2023-06-30 | - | 61000 |
2023-03-31 | - | 60000 |
2022-12-31 | - | 60000 |
CGTX
Price: $1.93
52 week price:
Earnings Per Share: -0.86 USD
P/E Ratio: -2.87
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 239600
Market Capitalization: 74.5 million